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May Supplement 200928S Poster PresentationsLimb amputation after failed bypass surgery is a feared complication and
might affect prognosis negatively. We aimed to identify and assess the
prognosis of patients requiring an amputation after previous arterial revas-
cularization.
Methods: For 834 patients who underwent peripheral arterial revascu-
larization for limb ischemia, cardiovascular risk factors, medication use and
postoperative complications were noted. During a median follow-up of 6.8
years limb and survival status were noted. Major amputation was defined as
amputations above the ankle. Survival status was assessed by contacting the
civil service registry. The primary end-point was all-cause mortality.
Results: A total of 834 patients were analyzed of which 194 (23%)
underwent a reoperation. During follow-up major amputations were neces-
sary in 161 (19%) patients. Patients who required amputation were more
likely to be smokers, had more cardiac risk factors and had more periopera-
tive complications during the index procedure. Statin use was associated
with a 35% relative risk reduction for major amputation. In univariate
analysis patients who required an amputation had a 1.6 fold increased risk for
mortality (figure). After adjusting for underlying cardiac risk factors and
medication use, amputation was still associated with a 1.3-fold increased risk
for mortality (95% CI 1.0-1.6, p0.02).
Conclusion: Patients who require a limb amputation during follow-up
after peripheral arterial revascularization have a worse prognosis compared
to patients who remain amputation-free.
Author Disclosures: G.M.J. Welten, None; O. Schouten, None; T.A.
Winkel, None; H.J.M. Verhagen, None; R.T. van Domburg, None; J.J.
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Objectives: To elucidate the prevalence and the prognosis of patients
with peripheral arterial disease (PAD) who have reduced endogenous anti-
coagulation protein activity in the Japanese population.
Methods: 96 patients with PAD were studied, including 45 patients
with intermittent claudication and 51 with critical limb ischemia. Among
them 65 patients undertook a peripheral artery bypass grafting and were
followed for the mean period of 26  31 months. Venous blood samples
were obtained and plasma activity level and antigen titer of Protein C (PC),
Protein S (PS), Plasminogen (PLG), Antithrombin (AT) were measured.
Based on the patients’ clinical database the prevalence and clinical relevance
was studied.
Results: Result 1. In our PAD patients PC activity is reduced in 18.8%,
PS activity is reduced in 16.7%, PLG activity was reduced in 15.6% and AT
activity was reduced in 24.0%. The incidence of AT activity deficiency was
significantly higher in patients with critical limb ischemia than patients with
claudication (p0.01). Result 2. After revascularization, 1, 3 and 5 year
event free rate of patients with PC or PS activity deficiency are 53, 30, 15%,
respectively, whereas those of patients without PC and PS deficiencies are
80, 64, 38%, being significantly higher rates (p0.05, Mantel-Cox test).
Also, 1, 3 and 5 year event free rate of patients with PLG activity deficiency
are 38, 0, 0%, respectively, and those of patients without PLG activitydeficiency are 79, 62, 34%, being significantly higher (p0.01, Mantel-Cox
test). Result 3. The percentage of thromboembolic episodes was signifi-
cantly high in patients with reduced PC activity compared with those with
normal PC activity (29.4% vs 7.6%, p0.05). Result 4. Patients with PC
activity deficiency were more susceptible to leg amputation (6 patients,
35.3% of patients with deficiency) than those without (10 patients, 12.7% of
patients without deficiency) (p0.01).
Conclusions: The PAD patients with reduced endogenous anti-coag-
ulation proteins shows worse prognosis than those without. Surgeons must
be aware of it to improve the outcome of arterial revascularization.
Author Disclosures: H. Komai, None; H. Shigematsu, None; M. Juri,
None.
PP48.
Chronic Atherosclerotic Occlusion of the Abdominal Aorta: A Con-
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Objective: Chronic atherosclerotic abdominal aortic occlusion
(CAAAO) is a rare and complex form of aortic disease. Few modern series
reviewing abdominal aortic reconstruction for CAAAO exist. Thus, we
sought to examine a current experience reviewing surgical techniques and
outcomes.
Methods: Between January 1997 through December 2008, 51 pa-
tients with CAAAO were identified and retrospectively reviewed. CAAAO’s
were categorized into pararenal aortic occlusions (PRAO’s) and infrarenal
aortic occlusions (IRAO’s) based on superior extension of thrombus and
requirement for supra-renal aortic clamping (SR-AC). Mortality, morbidity,
hospital stay and operative variables were assessed. Univariate analyses were
performed to test for associations between operative variables and primary
outcomes.
Results: Fifty patients were treated. 47 underwent aortic reconstruc-
tions with aorto-bifemoral or iliac (ABF-I) bypass and 3 had axillo-bifemoral
(AXBF) repairs. There were 32 males, 18 females (mean age 53 years, range
32-72). Severe claudication was present in 32, 17 had critical limb ischemia
(CLI) and 1 presented with ARF. There were 31 PRAO’s and 20 IRAO’s.
IRAO’s had infrarenal clamps (IRC) and aortic engraftment. In PRAO’s,
(SR-AC) was employed with aortorenal- thromboendarterectomy (AR-
TEA) in (24/30) 76%, 3 AR-TEA’s were blind with IRC and 3 AXBF’s were
performed. Of PRAO’s with AR-TEA, repairs were end-to-end: 14 sewn to
the renal bearing aorta; 10 were infrarenal after longitudinal pararenal
aortotomy, AR-TEA and primary aortic closure. Renal revascularization was
required in only 12% (6/50). Operative mortality at 30 days was 0. Cardio-
pulmonary dysfunction occurred in 4 (8%). Post-operative renal insuffi-
ciency was found in 10 (20%). Temporary dialysis was required in 1 (2 %).
Those with renal insufficiency in the post-operative period recovered to
baseline at discharge. Median ICU and hospital stay were 3 and 7 days
respectively. Analysis reveals associations only between prolonged hospital
stay and intra-operative blood replacement (p  0.001).
Conclusion - Abdominal aortic reconstruction is a safe method for
treating CAAAO. In CAAAO, SR-AC followed by AR-TEA and aortic
replacement is an effect solution for pararenal aortic disease and can be
performed without significant renal impairment.
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Objective: Acute thrombosis of a popliteal artery aneurysm (PAA)
often results in critical limb ischemia of sudden onset, with a compromised,
disastrous runoff, making direct revascularization hazardous. Pre-operative
thrombolysis may simplify or even make arterial repair redundant by reopen-
ing crural arteries and restore the outflow. Systemic review was performed to
study clinical outcome of both treatment modalities.
Methods: A systemic review was conducted of data on thrombosed
popliteal artery aneurysms in the English literature from 1990 using the
Pubmed and MEDLINE electronic databases up to Jun 30rd 2008.Results: The literature search identified no randomized trials, 8 pro-
spective studies, and 25 retrospective studies on the management of acute
